Home / 2020 / November / 18

Daily Archives: November 18, 2020

Feedzai launches new solution to democratize the fight against financial crime

  • “Feedzai Solutions” will support digital-first evolution for financial institutions of all sizes using a cloud-only environment
  • Over 40% of Feedzai customers already benefit from cloud-based solutions
  • New offering doubles-down on deployment agility, operational efficiency, industry expertise, and affordability while offering an out-of-the-box experience

SAN MATEO, Calif., Nov. 18, 2020 (GLOBE NEWSWIRE) — Feedzai announced today its new fully packaged Feedzai Solutions that can assess risk for single and cross-channel transactions in real-time. With the configuration of machine learning models taking just days instead of months, and a comprehensive library of out-of-the-box scenarios, the new offering presents itself as an agile, easy to deploy, and low resource solution for financial institutions of all sizes that are looking to better protect their customers with quicker time to value.

Feedzai helps financial institutions’ digital-first evolution by leveraging tech components especially critical during a severe digital acceleration journey amid the COVID-19 pandemic. The solution scalability allows financial institutions to improve time to market, while the cloud-based approach enables lightweight flexibility to transform and keep up with customer expectations. Additionally, best-in-class detection capabilities and real-time scoring help financial institutions to filter both new COVID-19 created and old fraudsters.

Cloud-based solutions have always been part of Feedzai’s enterprise portfolio with multiple deployments in all geographies and over 40% of the customers benefiting from it. Recently, this shift has intensified with more than 70% of Feedzai customers in the last 10 months – including globally-recognized Banks and Fintechs – choosing hosted cloud deployments. With this new offering, Feedzai leverages years of experience in operating some of the largest risk management projects across industries in a cloud environment, while also offering access to cutting edge risk management technology that otherwise would only be available to large financial institutions.

Best-in-Class Detection

  • Using Feedzai’s best-in-class technology as a framework, financial institutions of every size can now detect financial crime more efficiently by benefiting from advanced machine learning algorithms and segment-of-one profiling capabilities while also accessing one of the most comprehensive fraud networks in the world.

Operational Efficiency Boost

  • Rather than relying on multiple tools for each individual customer touchpoint, Feedzai’s all-in-one fraud prevention tool ensures that teams can manage risk exposure across the entire customer journey. One consistent tool enables straightforward maintenance, upgrades, data integrations, and orchestration.

Lightweight, Easy-to-Manage, Tangible ROI

  • Feedzai provides an out-of-the-box, cloud-based solution that can perform in days, not months, allowing customers to benefit from finely-tuned model performance on day one. Rather than spending critical time and significant resources in the configuration stage, risk management teams are now able to achieve tangible ROI in a short amount of time. Best-practice APIs that collect the necessary data for its workflows are also available in the new solution. ISO8583 and ISO20022 compatible APIs allow Feedzai to easily plug into the Financial Institution’s ecosystem.

Customer-centric Experience

  • Truly seamless multi-channel experiences by gathering real-time data and using analytics to understand the customer journey and allow financial institutions to have visibility on the entire risk management cycle.
  • According to Aite, “the scalability of Feedzai’s offering to support a high volume with low latency, as well as the platform’s ability to crunch an enormous amount of data from multiple touchpoints, are also cited as key strengths by a couple of the executives interviewed.” In one bank executive’s words, “Feedzai was built from ground up with scalability and big data in mind, versus others who are trying to adapt legacy technology to bring these in.”

Turnkey Compliance

  • Models, configurations, and best-practices are pre-packaged and comply with regulations such as OCC 2011, SR 11-7, and other legal guidelines. Additionally, Feedzai monitors and explains the system’s overall behavior while providing full autonomy when informing regulators what profiles and features have been created and why decisions were made, thus enhancing transparency and explainability.

Full Risk Life Cycle Orchestration

  • Feedzai’s risk orchestration approach offers unified risk tools and a reporting framework that facilitates operational gains across business lines, a particularly important challenge during COVID time where teams are looking to overcome inefficiencies. Feedzai’s new offering propels a cohesive risk strategy that, at its core, collates information from all perspectives into a single unified decision. Feedzai’s Full Risk Lifecycle Orchestration approach also increases scoring and internal monitoring accuracy, allowing small to midsize teams to discover and stop previously hidden financial crime.

Feedzai now serves over 800 million customers in 190 countries, but our aspirations do not stop there. We believe that by democratizing the fight against financial crime and making AI available to a variety of financial institutions that otherwise wouldn’t have access to it, we’re allowing risk management to become a level-playing field,” said Pedro Barata, SVP of Product. “Financial institutions of all sizes can now count on easy to deploy, best-in-class technology to support their financial crime challenges.”

Feedzai’s new product offering combines the power of multiple systems into one, allowing smaller teams with limited resources to manage risk and financial crime more efficiently. Instead of building an in-house platform or plugging in several complementary solutions that would require a significant amount of investment and resources to maintain, financial institutions can now rely on a fully orchestrated system fuelled by advanced AI to provide anti-fraud and AML while being fully compliant with national and international regulations.

Feedzai Solutions is now fully available in every region.

About Feedzai
Feedzai is the market leader in fighting financial crime with AI. We’re coding the future of commerce with today’s most advanced risk management platform powered by big data and machine learning. Founded and developed by data scientists and aerospace engineers, Feedzai has one mission: to make banking and commerce safe. With more than 500 employees, Feedzai is considered best-in-class by Aite and one of the most successful AI companies by Forbes. The world’s largest banks, processors, and retailers use Feedzai’s fraud prevention and anti-money laundering products to safeguard trillions of dollars and manage risk while improving customer experience.

Press Contact – Feedzai
Igor Carvalho
Head of Corporate Communications, Feedzai
igor.carvalho@feedzai.com

New Proprietary Research from Aptean Shows Strengthening Focus on Digital Transformation in Food and Beverage Industry

Study with Reuters Events Finds Biggest Barriers to Digital Adoption are Know-How and Ability to Integrate

ALPHARETTA, Ga., Nov. 18, 2020 (GLOBE NEWSWIRE) — Despite global business challenges caused by the COVID-19 pandemic, results of an exclusive new study reveal that food and beverage companies and influencers continue to invest in digital technologies that advance productivity, efficiency, sustainability and food safety. In terms of inhibitors to more digital adoption, 51% of industry respondents cited knowing how to use and integrate technology as being the biggest barrier. Lack of budget was also a major factor identified in the report, with 50% of respondents selecting the issue as one of their top three barriers.

The study—commissioned by Aptean, a global provider of mission-critical enterprise software solutions, and conducted on a blind basis in the U.S. and UK by international news and media organization Reuters Events—polled over 300 C-suite food and beverage executives and thought leaders in the field. The results were exclusively presented at Aptean’s inaugural Food and Beverage 2020 Global Symposium last week.

Quantitative research from the study indicates that over three-quarters of food and beverage industry respondents are currently increasing or maintaining their investments in digitalization. Not only are they investing in digitalization, 64% reported seeing good or advanced progress in the move to digital.

“While there is a significant move to digital technologies across the food and beverage industry, it’s interesting to see that companies hesitating to invest found know-how to be even more critical than budget,” said TVN Reddy, CEO of Aptean. “In part, the data shows delayed decisions are due to lack of internal knowledge about how to integrate new technologies with existing processes. For these companies, partnering with the right provider that’s deeply focused on improving manufacturing operations through technologies specifically built for their industry is a critical step to ensuring success throughout a digital transformation journey.”

Vonnie Estes, Vice President of Technology at the Produce Marketing Association, explained, “The problem of integration has been one of the biggest barriers to more adoption, but technological evolution is changing this for the better. Businesses struggle with interoperability and tons of data that doesn’t mesh. Now, companies like Aptean are coming along and saying, ‘let me gather all that stuff for you into one graph on a dashboard—we’ll train you and show you the way.’”

The research also indicates that there are clear areas where digital technologies are already having a strong impact across the food chain. Supply chain operations emerged as offering the highest reward, with 51% of respondents choosing it as one of the top business functions where they are benefiting from technology. Other areas in which digital transformation is creating impact are in data capture (38%) and reporting and business analytics (37%).

Additional key findings and success drivers that will help businesses understand the state of the industry while enabling strategic technology and planning investments for now and the future are available in Aptean’s “Global Food & Beverage Industry Trends Report,” published today and co-authored with Reuters Events.

About Aptean
Aptean is one of the world’s leading providers of industry-specific software. Our enterprise resource planning and supply chain solutions are uniquely designed to meet the needs of specialized manufacturers and distributors in over 20 industries, while our compliance solutions serve specific markets such as finance and life sciences. In total, Aptean’s solutions are used by over 6,000 customers around the world. With both cloud and on-premise deployment options, Aptean’s products, services and unmatched expertise help businesses of all sizes to scale and succeed. Aptean is headquartered in Alpharetta, Georgia and has offices in North America, Europe and Asia-Pacific. To learn more about Aptean and the markets we serve, visit www.aptean.com.

Aptean is a trademark of Aptean, Inc. All other company and product names may be trademarks of the respective companies with which they are associated.

For Media Inquiries Please Contact
Nicole O’Rourke
Chief Marketing Officer
Nicole.Orourke@aptean.com
(770) 715-0362

Leading pathology laboratories deploy tele-diagnostics with Philips during the COVID-19 pandemic

November 18, 2020

  • Pathology laboratories around the globe fully digitize tumor tissue samples to maintain the patient diagnostic experience while providing for staff safety
  • Digital transformation modernizes cancer care by enabling telehealth and the use of artificial intelligence (AI) while supporting physicians with integrated oncology informatics

Amsterdam, The Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced leading pathology laboratories across North America, Europe, and Asia have implemented full digitization for their histology samples based on the Philips Digital Pathology scanner and imaging-informatics solutions. Digital images are required to unlock the potential of digital pathology. Remote reviewing of pathological cases is essential to prevent delay in critical patient diagnosis and care, particularly during COVID-19.

During the pandemic, many pathologists, oncologists, and radiologists continued their work from home. This created an unprecedented need for home workstations and secure clinical informatics solutions allowing clinicians to read images remotely and enabling real-time virtual collaboration between their multi-disciplinary care teams. Pre-COVID-19, pathology labs that digitized their workflows across different sites reported improved collaboration and an average productivity gain of 21%.

Examples of leading pathology laboratories that recently transformed towards a digital workflow with Philips IntelliSite Pathology Solution are:  Mackenzie Health (Canada), Pathology Institute Tel Aviv Sourasky MC (Israel), University Medical Center Groningen (Netherlands), St. Olavs Hospital (Norway), Singapore General Hospital SGH (Singapore), Oxford University Hospitals NHS (UK), and NHS Ayrshire & Arran (UK).

“As healthcare becomes more complex and demanding, digitization has become a key enabler for the hospital to provide better care for our patients and to be more efficient. Digital pathology is an example, and our partnership with companies such as Philips with the clinical and technical know-how is important in helping us achieve our goal,” said Prof. Kenneth Kwek, Chief Executive Officer at Singapore General Hospital SGH.

“COVID-19 has become a catalyst for change – a defining moment for all of us to reimagine healthcare the way it should be,” said Kees Wesdorp, Chief Business Leader, Precision Diagnosis at Philips. ”With a focus on the people at the center of cancer care, we work to innovate workflows, remove barriers of fragmented systems, and bring insights directly to care providers to support excellent cancer care.”

Shared decision-making, pathway selection and treatment
Philips’ solutions for oncology and digital pathology can help transform and enhance the multi-disciplinary workflows, including the oncology tumor board and care pathways process. Critical patient data is integrated for both oncologists, radiologists and pathologists, allowing them to collaborate efficiently, even when working remotely. The Philips platform supports streamlined preparation, enhances review and analysis, and empowers the cancer care team to reach clinical treatment decisions based on disease-specific dashboards, diagnostic images, reports, and structured patient data. Visit Philips Digital Pathology for more information on how Philips is enhancing digital pathology workflows. Visit Philips Live at RSNA 2020 to learn  how Philips integrated workflow solutions connect data, technology and people across the diagnostic enterprise, helping to redefine radiology workflow efficiencies.

For further information, please contact:

Kathy O’Reilly
Philips Global Press Office
Tel.: +1 978-221-8919
E-mail : kathy.oreilly@philips.com
Twitter: @kathyoreilly

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 81,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Attachments

Servion Global Solutions and Jacada Join Forces to Build Automation-First Contact Centers & Deliver Effortless Customer Experiences

Servion and Jacada partner to deliver automation-first contact centers

Jacada and Servion Global Partnership

ATLANTA, Nov. 18, 2020 (GLOBE NEWSWIRE) — Jacada, Inc., a pioneer of intelligent customer service automation, has announced its newest strategic partner, Servion Global Solutions, a leading Contact Center and Customer Experience (CX) solution provider headquartered in Princeton, NJ. The partnership enables Servion to resell, deploy and support Jacada’s entire customer service automation portfolio globally.

Businesses continue to compete on customer experience more so than on price or product. The pandemic has only exacerbated the challenges for laggards in this race, even as customer experience leaders contend with newer challenges — anxious customers, drastic changes in the supply chain and a work-from-home workforce.

While cloud adoption, artificial intelligence and automation are commonly found in recipes for recovery and reimagination beyond the pandemic, contact center leaders must move forward with a data-driven mindset and plan for sustainable progress, not just the rapid deployment of various technologies. That’s easier said than done, and that’s why Jacada and Servion are partnering to put the power of Jacada’s low code contact center automation suite in the hands of Servion’s trusted consultants and engineers who have been designing and delivering game-changing contact center and customer experience solutions for over 25 years.

“As the customer experience technology stack, particularly, in an around the contact center, gets more complex, diverse, and disparate, Jacada’s low code middleware for contact center automation comes in handy to harmonize enterprise silos and elevate the customer experience in record time and cost,” mentioned Yochai Rozenblat, CEO of Jacada. “Servion’s trusted expertise in designing and delivering such contact center and customer experience transformations makes for a partnership designed for value creation,” he added.

“We are excited to partner with Jacada to extend our CX and Contact Center capabilities with their AI-powered self-service and robotic process automation technology,” said Laurent Philonenko, CEO at Servion Global Solutions. “Servion’s expertise in implementing and managing technology solutions combined with Jacada’s innovative products will allow us to further enhance customer and agent experience across multiple channels, reduce operational costs, and improve overall business efficiency for customer service or sales,” he added.

While Jacada and Servion have collaborated previously, the companies have now made the partnership more strategic and global to accelerate digital transformation initiatives for clients particularly interested in scaling conversational AI and robotic process automation within the customer operation. The global Servion team has gone through a formal enablement process and is ready to help clients harmonize silos and elevate their customer experience.

About Jacada

Jacada is a global enterprise software provider in the customer service automation space, with award-winning robotic process automation and conversational AI capabilities. Our clients and partners use Jacada Interact, our low code automation platform, to design, build and manage intelligent virtual agents for their customers and employees. Solutions harmonize silos and elevate CX in weeks without having to rip or replace existing assets.

About Servion Global Solutions

For more than 25 years, Servion has been trusted by customer-centric brands for architecting, implementing, and managing Contact Centers and Customer Experience (CX) solutions. Servion delivers complete solutions for businesses to innovate in providing digital experiences using the best available technologies while maximizing their existing investments. Our 1,000 CX professionals apply their passion and deep domain expertise to the entire build-run-optimize solution lifecycle. Servion has helped 600 enterprises across the globe deliver great experiences to their customers, partners, and employees. For more information, visit https://www.servion.com.

For press inquiries, contact Scott Merritt via phone at 770-361-5900 or email at smerritt@jacada.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/03b8e27b-d501-4841-8b6e-f669c2325fed

iRemedy™ Secures Factory Capacity for Needles and Syringes Required for Administration of One+ Billion COVID-19 Vaccinations

STUART, Fla., Nov. 18, 2020 (GLOBE NEWSWIRE) — The iRemedy Healthcare Companies, Inc. (“iRemedy” or “the Company”), pioneer of the iRemedy™ medical supply marketplace, today announced that in anticipation of COVID-19 vaccines becoming available soon, the Company has procured factory capacity for production of over one billion, FDA-approved hypodermic needles and syringes that will be required for administration of vaccinations to the public on a global basis.

iRemedy has already procured over 50 million units and has arranged for weekly deliveries from its factory partners through 2021. Current factory production cycles expect to result in the delivery of approximately 100 million units per month.

According to information published on the Regulatory Affairs Professionals Society website, there are currently ten vaccine candidates in Phase 3 trials and an additional 41 in Phase 1, Phase 2 or pre-clinical stages of research and development. However, the World Health Organization reports that there are more than 100 COVID-19 vaccine candidates in development. As of this week, more than 50 million cases of COVID-19 have been recorded worldwide as countries hit new records globally. The United States, alone, has surpassed 10 million cases. The need for a vaccine is clearly pronounced and efforts to expedite clinical trials to ensure vaccine safety and efficacy is a key priority for nations across the planet. iRemedy is poised to play a key supporting role in the distribution of the vaccines by providing needles, syringes and related supplies.

Tony Paquin, CEO of iRemedy, stated, “If we are to arrest the spread of COVID-19 and restore any meaningful sense of normalcy to society, the widespread administration of a vaccine or vaccines remains paramount – and it appears that key players in the biopharmaceutical industry are close to receiving approval of their respective vaccines in development. In view of this, iRemedy recognizes that FDA-approved hypodermic needles and syringes will be in extraordinarily high demand on a global basis once vaccines have cleared Phase 3 trials and are approved for use by government regulatory agencies in countries around the world. To ensure that iRemedy’s clients here and abroad are in the position to meet this anticipated global demand, we started procuring factory production.”

Continuing, Paquin added, “With production of over one billion needles and syringes secured, iRemedy looks forward to working with healthcare providers worldwide to help ensure that they can quickly commence their vaccination programs to help save lives and ultimately overcome the global pandemic once and for all.”

About The iRemedy Healthcare Companies
With 15 years in healthcare supply, iRemedy is a trusted and reliable partner for acquiring medical supplies and Personal Protective Equipment. We service over 5,000 healthcare provider, commercial and government clients nationwide. We guarantee access to verified supplies by sourcing directly from established manufacturers and distributors around the world. Our industry-leading technology and group purchasing power enable transparency and competition, driving consistently low pricing for our customers every day. iRemedy is headquartered in Stuart, Florida and has offices in New York, California and Washington, and distribution centers in Florida and Arizona. For more information, please visit www.iRemedy.com.

FOR MORE INFORMATION:
Keisha Graham
407-395-4283 | keisha@iremedy.com

OR FOLLOW US ON:
Facebook
Twitter
LinkedIn
Instagram

Teledyne Imaging announces development of new generation of CMOS sensors and cameras

THOUSAND OAKS, Calif., Nov. 18, 2020 (GLOBE NEWSWIRE) — Teledyne Imaging, part of Teledyne Technologies, announces the development of a new generation of CMOS sensors and cameras. The initiative involves several groups within Teledyne Imaging, focused on the development, fabrication, and supply of CMOS detectors and cameras for the scientific research and commercial markets including astronomy, soft X-ray, microscopy, spectroscopy and biomedical imaging.

“We are very pleased to launch this new initiative,” states Edwin Roks, Group President of Teledyne Digital Imaging. “This is a natural extension of our legacy of sensor and camera development in both CCD and CMOS, and is designed to meet the needs of emerging markets and applications. It represents the strength of the Teledyne organization, and the value of the acquisition strategy we have implemented, by combining our expertise across several business units, from sensor design to cameras and system interface.”

These new initiatives will meet the increasing demand for higher performing sensor technology by combining essential elements of both CCD and CMOS sensors in a new generation of devices that are distinctly different from anything currently available on the market. Our customers, in nearly every vertical market segment, are asking for the optimal combination of resolution, pixel size, sensitivity and speed. These new designs will include multiple imaging formats up to 66 megapixel, quantum efficiency up to 95%, as well as ultra-low noise and high speed readout. Teledyne will also incorporate their expertise in sensor and electronic cooling to further increase performance.

The project will combine the efforts of multiple groups at Teledyne Digital Imaging segment with over five decades of experience in advanced CCD and CMOS detector and camera technologies. The first sensor and camera prototypes will be available in Q4 2021, with full scale production in 2022.

About Teledyne Imaging

Teledyne Imaging is a group of leading-edge companies aligned under the Teledyne Technologies umbrella. Teledyne Imaging forms an unrivalled collective of expertise across the spectrum with decades of experience. Individually, each company offers best-in-class solutions. Together, they combine and leverage each other’s strengths to provide the deepest, widest imaging and related technology portfolio in the world. From aerospace through industrial inspection, scientific research, spectroscopy, radiography and radiotherapy, geospatial surveying, and advanced MEMS and semiconductor solutions, Teledyne Imaging offers world-wide customer support and the technical expertise to handle the toughest tasks. Their tools, technologies, and vision solutions are built to deliver to their customers a unique and competitive advantage. To register for more information please contact Debby Flint-Baum (debby.flint-baum@teledyne.com).

About Teledyne Technologies

Teledyne Technologies is a leading provider of sophisticated instrumentation, digital imaging products and software, aerospace and defense electronics, and engineered systems. Teledyne’s operations are

primarily located in the United States, Canada, the United Kingdom, and Western and Northern Europe. For more information, visit Teledyne’s website at www.teledyne.com.

Media Contact:
Debby Flint-Baum, Teledyne Imaging
Tel: +1 978 268 0327 | debby.flint-baum@teledyne.com

Vivek Goel named president and vice-chancellor of the University of Waterloo

Innovator, scholar and bold leader becomes university’s seventh president

Vivek Goel

Vivek Goel will become the seventh president and vice-chancellor of the University of Waterloo. He begins his five-year term on July 1, 2022. “In Waterloo, I can see what a post-pandemic university looks like,” Goel said.

WATERLOO, Ontario, Nov. 18, 2020 (GLOBE NEWSWIRE) — Vivek Goel, a distinguished scholar with extensive achievements in research, teaching and leadership across both public and private sectors, will become the seventh president and vice-chancellor of the University of Waterloo.

Goel, who begins his five-year term on July 1, 2021, is recognized in Canada and around the world as a leading public-health researcher, health-services evaluation expert, and champion for the use of research evidence in health policymaking.

Goel has held several senior roles at the University of Toronto, including Vice-President and Provost and most recently as Vice-President of Research and Innovation.

The public health physician currently serves as a member of the federal government’s COVID-19 Immunity Task Force and Scientific Advisor for the CanCOVID Research Network. He was previously the founding president and CEO of Public Health Ontario.

“Dr. Goel has decades of experience and expertise as a university leader and as a champion of student experience, research and innovation. He is uniquely qualified to guide the institution and to bolster our strengths at the intersection of health, society and technology,” said Cindy Forbes, Chair of the University of Waterloo’s Board of Governors.

Goel said the current global situation reminds us of our responsibility to prepare students and citizens to confront the many challenges ahead. “A research-intensive institution like Waterloo is ideally poised to create the change and solutions for a better future – whether it is tackling public-health challenges, addressing systemic racism, dealing with the climate crisis, or spurring economic recovery and growth.”

“In Waterloo, I can see what a post-pandemic university looks like,” he said.

The appointment represents the culmination of an almost yearlong effort by a 19-member presidential nominating committee comprised of students, staff, faculty and board governors, in consultation with stakeholders across campus and the broader community.

“The Presidential Nominating Committee sought a candidate who is renowned for their experienced leadership and is committed to the success of faculty, staff, students and alumni,” Forbes said. “We looked for an individual who will actively engage to foster equity, diversity and inclusion as well as a deep sense of community across our campuses.”

“I look forward to working with Dr. Goel as he leads Waterloo on its transformational path and builds on the achievements of President Feridun Hamdullahpur.”

Hamdullahpur has served as president and vice chancellor of the University of Waterloo since 2010 and will continue through June 2021. He has elevated Waterloo’s international profile, placed exceptional focus on student experience and wellbeing and set the ambitious course for the University’s 2020-2025 strategic plan.

“Waterloo is a place where business, community and governmental leaders come together to seek today’s solutions to tomorrow’s problems. I am confident that under the leadership of Vivek Goel, our community will continue to flourish and drive even greater impact around the world,” Hamdullahpur said.

Goel obtained his medical degree from McGill University. He did his post-graduate medical training in community medicine at the University of Toronto, and obtained a master’s degree (MSc) in health administration from the University of Toronto and a master’s degree (MS) in biostatistics from Harvard University’s School of Public Health.

Goel also currently serves on the boards of the Vector Institute, TRIUMF—Canada’s particle accelerator—and the Canadian Institute for Health Information.

Contact
Chris Wilson-Smith
Director, media relations
chris.ws@uwaterloo.ca

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/41a37aaa-d8eb-4963-bf22-f174c9902c2f

For more information, visit: uwaterloo.ca/next-president/